SCHEMBL13046239

SCHEMBL13046239

c1ccc(-c2ccc3c(-c4ccccc4)c(-c4ccc(-c5ccc6c(-c7ccccc7)c7ccccc7c(-c7ccccc7)c6c5)cc4)c4ccc(-c5ccccc5)nc4c3n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 6/20 0.38
▸ ESR2 Q92731 5/20 0.38
▸ DHODH Q02127 2/20 0.38
▸ ALK Q9UM73 1/20 0.38
▸ MEN1 O00255 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ DHFR P00374 1/20 0.36
▸ ENPP1 P22413 1/20 0.36
▸ ACHE P22303 1/20 0.36
▸ ALDH1A2 O94788 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ ALDH1A3 P47895 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ JAK2 O60674 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13046213 1.00 ESR1 (0.38) ESR1ESR2DHODHALKMEN1
SCHEMBL13046224 0.94 MEN1 (0.39) ESR1ESR2DHODHALKMEN1
SCHEMBL13046179 0.92 MEN1 (0.43) ESR1ESR2ALKMEN1RAB9A
SCHEMBL13046193 0.92 MEN1 (0.43) ESR1ESR2ALKMEN1RAB9A
SCHEMBL13046201 0.92 ADORA1 (0.43) ESR1MEN1RAB9AKMT2AMAPT
SCHEMBL10353755 0.91 ESR1 (0.41) ESR1ESR2DHODHALKMEN1
SCHEMBL20250422 0.91 ESR1 (0.41) ESR1ESR2DHODHALKMEN1
SCHEMBL20250449 0.88 ESR1 (0.39) ESR1ESR2DHODHALKMEN1
SCHEMBL20250444 0.88 ESR1 (0.41) ESR1ESR2DHODHALKMEN1
SCHEMBL12577825 0.87 PARP1 (0.40) ESR1ESR2DHODHALKALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023080187-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE 出光興産株式会社 2023-05-11 — — WO disclosed
US-11552259-B1 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-01-10 — — US disclosed
US-20220393113-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-08 — — US disclosed
US-10573823-B2 Organic electroluminescent device JOLED INC (JP) 2020-02-25 — — US disclosed
EP-2833429-B1 ORGANIC ELECTROLUMINESCENCE ELEMENT JOLED INC (JP) 2019-09-18 — — EP disclosed
US-9978975-B2 Organic electroluminescence device JOLED INC (JP) 2018-05-22 — — US disclosed
US-9978975-B2 Organic electroluminescence device JOLED INC (JP) 2018-05-22 — — US disclosed
US-20150303380-A1 ORGANIC ELECTROLUMINESCENT DEVICE MAGNOLIA BLUE CORPORATION (JP) 2015-10-22 — — US disclosed
US-20150303380-A1 ORGANIC ELECTROLUMINESCENT DEVICE MAGNOLIA BLUE CORPORATION (JP) 2015-10-22 — — US disclosed
US-20150069351-A1 ORGANIC ELECTROLUMINESCENCE DEVICE MAGNOLIA BLUE CORPORATION (JP) 2015-03-12 — — US disclosed
US-7834346-B2 Nitrogenous heterocyclic derivative and organic electroluminescence device making use of the same IDEMITSU KOSAN CO., LTD. (JP) 2010-11-16 — — US disclosed
US-7834346-B2 Nitrogenous heterocyclic derivative and organic electroluminescence device making use of the same IDEMITSU KOSAN CO., LTD. (JP) 2010-11-16 — — US disclosed
US-20100108990-A1 NITROGENOUS HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2010-05-06 — — US disclosed
US-20100108990-A1 NITROGENOUS HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2010-05-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100108990-A1 NITROGENOUS HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME CYBA, NUDC, NUDT1 ESR1 654/4885ESR2 675/4885DHODH 1042/4885
US-10573823-B2 Organic electroluminescent device L1CAM, NES, EML4 ESR1 23/4885ESR2 76/4885DHODH 2027/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback